Searched term >>> 

Mesenchymal stem cells

The results below show you the top matched VC  mesenchymal stem cells investors.

Olga joined Ruffena in September 2015 with experience in intellectual property, investment and innovation management, and technology translation with specialisation in advanced engineering, medical devices, and precision medicine technologies. Olga also holds positions as an Operations Director at New Medicine Partners, a global specialist advisory firm that accelerates the translation of new precision medicine technologies into commercial and clinical practice, and a Senior Consultant at Oxentia (formerly Oxford University Innovations’ consulting arm) and McGrigor Group, a global M&A advisory firm in health insurance and medical products and services. Olga holds a doctorate degree in Materials from the University of Oxford.

Location: London

Relevant content >>> "mesenchymal stem cells"

A groundbreaking new therapeutic approach was developed and tested to improve outcome in patients suffering from novel coronavirus (COVID-19) pneumonia. The new technique involves intravenous transplantation of mesenchymal stem cells (MSCs) into the patients. It was successfully tested in 7 COVID-19 patients, in Beijing YouAn Hospital, Capital Medical University, China. The results are published in the scientific journal Aging and Disease, entitled "Transplantation of ACE2- Mesenchymal Stem Cells Improves the Outcome of Patients with COVID-19 Pneumonia"  #medicine #stemcells #coronavirus #precisionmedicine #celltherapy #covid19

  • LinkedIn

A growing case for the use of #mesenchymal stem cells in treatment of #covid19, particularly in #elderly patients with severe symptoms and those experiencing  "cytokine storm". #stemcells #celltherapy #precisionmedicine #immunotherapy

  • LinkedIn

#Mesoblast receives clearance from the #FDA for an Investigational New Drug application to treat patients with acute respiratory distress syndrome (ARDS) caused by a #covid19 induced cytokine storm, reported to be the major cause of death of covid19 patients. The treatment involves intravenous infusions of its allogeneic mesenchymal stem cell product candidate Remestemcel-L.#celltherapy #precisionmedicine #stemcells

  • LinkedIn

Peter has over 20 years experience working as an entrepreneur, marketer, advisor and expert in technology commercialisation, digital marketing and new product launches. A digital pioneer Peter helped launch and manage three digital agencies; Holmes & Marchant Digital, Arc Worldwide and TBWA-GGT Digital, strategising for Global brands such as Coca-Cola, Mars, Procter & Gamble and News International.

Peter currently holds Board Advisor / Investment positions in a range of growing UK and US based businesses.

Location: London

Relevant content >>> "mesenchymal stem cells"

Five years ago these little beauties (my sister Clare McSheaffrey's stem cells) were infused into me in an underwhelming procedure which saved my life. Today marks a significant milestone in my journey. #bloodcancerawareness #stemcells #fiveyearsout

  • LinkedIn

Following a PhD in genetics at the University of Edinburgh and several post-doc roles in cancer research, Andrea worked in drug discovery within the pharmaceuticals sector (Smith Kline Beecham now GSK) and biotech (Oxford Glycosciences, latterly UCB).

Location: London

Relevant content >>> "mesenchymal stem cells"

It has been a pleasure to support Prof Steven Pollard at The University of Edinburgh and team to establish Cellinta, launched today, with investment from SV Health Investors and Cancer Research UK (CRUK). The company will develop selective gene therapies for targeting cancer stem cells. Edinburgh Innovations.

  • LinkedIn

Ship Shape helps you find the right VC investor in seconds, not months

Check out examples of  popular searches for investors by domain: